Medindia

X

Cipla's HIV Drug Gets FDA Approval

by Medindia Content Team on  June 26, 2006 at 9:53 AM Drug News   - G J E 4
Cipla's HIV Drug Gets FDA Approval
Pharma giant Cipla has received the approval from the Food and Drug Administration for its "abbreviated new drug application (ANDA) for anti-HIV/AIDS drug Slamivudine," according to a posting on the FDA site.
Advertisement

The website reported that the tentative approval for ANDA is for an oral solution with strength of 10mg per ml. The new drug belongs to a class of drugs called as nucleoside reverse transcriptase inhibitors. It stops the replication of the HIV virus and hepatitis B virus as well.

Advertisement
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
Indian companies lead by Cipla are doing a great service to the mankind by supplying Generice drugs to many countries under WHO and Clinton foundation.
guest Tuesday, June 27, 2006
Indian companies lead by Cipla are doing a great service to the mankind by supplying Generice drugs to many countries under WHO and Clinton foundation.
Shreekanth Tuesday, June 27, 2006
Cipla has done a great service to patients suffering from AIDS; even Bill Clinton acknowledged it when he visited their factory.
guest Monday, June 26, 2006

You May Also Like

Advertisement
View All